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Medicine in the West is increasingly focused on treating age-related diseases such as cancer and
cardiovascular disease. Are we now ready for the next big leap: to treat not just the symptoms
of aging but its underlying causes? This issue’s Select finds clues in hunchbacked mice, the
C. elegans epigenome, elderly bacteria, and 25 amino acids of Sirt1.BubR1 mutant mice exhibit accelerated aging phenotypes
such as spinal curvature (left). Some of these phenotypes
are rescued by selective killing of senescent cells (right).Senescent Suicide for a Long Life?
Cellular senescence is a potent tumor suppressor, putting
damaged cells into early retirement by halting their continued
division. However, the cocktail of growth factors, cytokines, and
proteases secreted by senescent cells has been shown to enhance
tumor progression in neighboring cells. Baker and colleagues now
show that senescent cells can also influence the apparent age of
the tissues in which they reside. They constructed transgenic
mice in which senescent cells can be selectively culled from tissues
by adding a drug. A drug-activated, proapoptotic fusion protein is
expressed under the control of a fragment of the p16INK4A
promoter, which becomes transcriptionally active as cells become
senescent. To test the effect of killing off senescent cells on theaging process, the investigators turned to a mouse model in which aging is dramatically accelerated. Mice mutant for the
mitotic checkpoint protein BubR1 develop age-related ailments including muscle wasting, spinal curvature, cataracts, fat
loss, cardiac arrhythmia, stiffening of the arterial walls, and thinning of the skin. The mice also accumulate p16INK4A-positive
cells in many of these tissues. Remarkably, selective killing of these senescent cells by treatment with the drug from 3 weeks
after birth significantly reduces some of the age-related pathologies caused by BubR1 deficiency: muscle wasting, spinal
curvature, and the appearance of cataracts are delayed, and fat loss is slowed. Luckily for those of us who may already
be feeling the effects of our advancing years, the investigators also tested whether killing senescent cells later in life could
have an impact. Mice treated with the drug from 5 months also saw significant benefits in the form of improved muscle func-
tion and fat retention. These results support the idea that senescent cells not only promote tumor progression but also impair
the function of surrounding tissue, presumably via the secretion of as yet unidentified factors. However, despite these positive
effects of removing senescent cells, in neither experiment did the treatment enhance life span. This may be because the likely
cause of death of the BubR1 mutant mice is cardiac arrest, a phenotype that is not driven by p16INK4A-expressing senescent
cells. It therefore remains to be seen whether the removal of senescent cells would enhance the health span and life span of
wild-type mice.
Baker, D.J., et al. (2011). Nature. Published online November 2, 2011. 10.1038/nature10600.E. coli—growing old gracefully.Young and Old Are Poles apart
Do bacteria grow old? What does it mean for a bacterium to grow old anyway? We’re
familiar with aging in budding yeast because these cells undergo replicative senes-
cence, and the signaling pathways influencing this form of aging are well conserved
in higher eukaryotes. However, the evidence for aging in prokaryotes is more contro-
versial. Bacteria such as E. coli apparently divide symmetrically, by forming a central
septum that divides the mother cell into two and becomes the ‘‘new’’ pole of the re-
sulting daughter cells. When these daughter cells themselves divide, one daughter
will receive an ‘‘older’’ pole than the other. Whether this has any functional conse-
quences, for example whether cells with older poles also receive a greater share of
oxidative damage, has proved difficult to assess. One recent study by Taddei and
colleagues tracked E. coli through multiple divisions and found that such older cells
grow progressively more slowly. However, subsequent experiments by Jun and
coworkers, in which the oldest bacteria are physically restrained in a microfluidic
device called the ‘‘mothermachine,’’ revealed that the growth rate of these cells remains remarkably constant over thousands
of generations. How can these two results be reconciled? Chao and colleagues have now taken the growth rate data from
both of these experimental systems and fed them into amathematical model that was previously used to investigate bacterial
evolution. Surprisingly, they found that both sets of data could in fact be easily explained by a single model, in which a given
mother cell doubling time defines two different doubling times for the resulting daughter cells via a simple linear relationship.Cell 147, November 23, 2011 ª2011 Elsevier Inc. 955
By iteratively applying the same formula over multiple generations, the model predicts that bacteria will tend towards two
different equilibrium doubling times or ‘‘attractors.’’ The older bacteria trapped in the mother machine correspond to the
slower of these attractor states, explaining why their growth rate fails to decrease over time but nevertheless supporting
the idea that E. coli divide asymmetrically into younger and older daughter cells. The model also reveals why asymmetry
and agingmight provide an evolutionary advantage over immortal symmetric division: lineages of cells that segregate damage
asymmetrically can tolerate higher levels of damage overall and have higher evolutionary fitness.
Rang, C.U., et al. (2011). Curr. Biol. 21, 1813–1816.H3K4me3 in the germline of C. elegans.
Image by Travis J. Maures.Life Span Coded in Chromatin
Several papers over the last few years have provided increasingly strong support for
the importance of epigenetic inheritance. Environmental factors such as stress and
diet modify chromatin to regulate gene expression, and these patterns of gene
expression appear to then be passed on through subsequent generations. Chromatin
modification, in particular trimethylation of H3K4, has been shown to influence life
span in C. elegans; worms lacking components of a protein complex responsible
for H3K4 trimethylation have an extended life span. If their long life is somehow en-
coded in chromatin, could the effect be passed on to their offspring even if these
offspring are no longer genetic mutants? In a set of simple but elegant experiments,
Brunet and coworkers demonstrate that the wild-type ‘‘grandchildren’’ of hermaphro-
dite worms homozygous for mutations in the H3K4 trimethylation complex retain their
ancestor’s enhanced life span. Incredibly, this increased life span is also passed on to
the next generation, only to be abruptly curtailed to wild-type levels in the generation
following that. Life span extension persists even though overall levels of H3K4 meth-
ylation appear normal in the genetically wild-type worms. Differences are, however,still apparent in theworms’ transcriptomes, with genes regulatingmetabolism being particularly affected in long-lived descen-
dants from H3K4 regulator mutant ancestors. Relatively subtle changes in H3K4 trimethylation at a specific subset of genes
may be sufficient to enhance life span, although it’s not yet clear why these genes are selectively susceptible to epigenetic
inheritance. Importantly, the epigenetic effect is only apparent when life span is enhanced through mutation of the H3K4 tri-
methylation complex. For example, even though genetic reduction of function of insulin signaling also increasesC. elegans life
span, this increase is not passed on to subsequent generations. This suggests that such metabolic changes probably do not
influence H3K4 trimethylation in the same way, if at all, and it will certainly be interesting to identify environmental or pharma-
cological factors that can induce such heritable changes.
Greer, E.L., et al. (2011). Nature. Published online October 19, 2011. 10.1038/nature10572.ESA peptide binding to the Sirt1 catalytic core pro-
motes deacetylase activity.Sirt1 Finds Its On Switch
Ever since it was shown that yeast Sir2 regulates life span, the Sirtuin family
of protein deacetylases has risen to superstar status in the aging field. Some
of this excitement undoubtedly stems from the finding that resveratrol,
a chemical found in red wine that is proposed to activate Sir2 and its higher
eukaryotic homologs, can combat a seemingly ever-growing list of age-
related problems and extend life span in worms, flies, and mice. However,
how and even whether resveratrol activates Sir2 and its homologs are
a matter of debate. Surprisingly, despite their central roles in sensing and
controlling cellular metabolism, relatively little is known about how the
activity of Sirtuins is regulated at a structural level. The closest mammalian
homolog of Sir2, Sirt1, comprises a catalytic core and aC-terminal extension
that is required for its catalytic activity. Chung and colleagues now identify a 25 amino acid peptide within this extension that is
sufficient to activate Sirt1 when attached to the catalytic core. This peptide sequence (known as ESA, essential for Sirt1
activity) is specific to Sirt1 and is not found in other members of the Sirtuin family. A known endogenous protein inhibitor
of Sirt1, DBC1, appears to inhibit Sirt1 deacetylase activity by competing with this peptide sequence for binding to the cata-
lytic core. Furthermore, mutation of two residues within the activation sequence generates a peptide that binds to the core but
fails to activate it. This mutant peptide inhibits Sirt1 when expressed in trans in vivo. Unfortunately, the corresponding wild-
type peptide cannot activate Sirt1 in trans. However as we eagerly wait for a crystal structure of Sirt1, the discovery of Sirt1’s
ignition key offers some early hope that specific small-molecule regulators of Sirt1 are within reach.
Kang, H., et al. (2011). Mol. Cell 44, 203–213.
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